Dey Indranil's Form 4 filing
Bluejay Diagnostics, Inc. (BJDX) · filed Mar 28, 2023
- Accession no.
- 0001213900-23-023546
- Filed
- Mar 28, 2023, 1:09 PM ET
- Trade date
- Mar 27-28, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001213900-23-025243 (Mar 31, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dey IndranilCIK 0001889815 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | Common Stock | AGrant or awardAcquired | +8,000 | $0.44 | +$3,520 | 558,538 | Direct | |
| Mar 28, 2023 | Common Stock | AGrant or awardAcquired | +2,000 | $0.44 | +$880 | 660,538 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.